We are live on
!
Find out more
DS
Dudley & Shanley Portfolio holdings
AUM
$662M
1-Year Est. Return
10.7%
This Fund
S&P 500
This Quarter
Est. Return
-0.36%
1 Year Est. Return
+10.7%
3 Year Est. Return
+57.04%
5 Year Est. Return
+90.57%
10 Year Est. Return
+304.94%
AUM
$538M
AUM Growth
-$40.1M
(-6.9%)
Cap. Flow
-$28.1M
Cap. Flow
% of AUM
-5.23%
Top 10 Holdings %
Top 10 Hldgs %
61.09%
Holding
37
New
1
Increased
4
Reduced
2
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.8M |
| 2 |
ProShares UltraPro Short S&P 500
SPXU
|
+$1.65M |
| 3 |
Ryan Specialty Holdings
RYAN
|
+$1.37M |
| 4 |
Allison Transmission
ALSN
|
+$157K |
| 5 |
MNRL
Brigham Minerals, Inc. Class A Common Stock
MNRL
|
+$129K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$23M |
| 2 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$11.9M |
| 3 |
Saic
SAIC
|
+$5.67M |
| 4 |
Travelers Companies
TRV
|
+$857K |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$584K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.87% |
| 2 | Consumer Discretionary | 19.15% |
| 3 | Healthcare | 18.16% |
| 4 | Materials | 16.91% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Roper Technologies
ROP
$39.4B
| $1.2M | 0.22% |
2,550
| – | – |
|
27
iShares Core S&P 500 ETF
IVV
$872B
| $859K | 0.16% |
1,893
| – | – |
|
|
MNRL
28
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $557K | 0.1% |
21,800
+5,550
| +34% | +$129K |
|
29
Corpay
CPAY
$25.3B
| $395K | 0.07% |
1,585
| – | – |
|
30
Pfizer
PFE
$144B
| $311K | 0.06% |
6,000
| – | – |
|
|
31
Travelers Companies
TRV
$82.9B
| $256K | 0.05% |
1,400
-5,000
| -78% | -$857K |
|
32
HEICO Corp
HEI
$49.9B
| $236K | 0.04% |
1,540
| – | – |
|
33
Kadant
KAI
$3.75B
| $225K | 0.04% |
1,160
| – | – |
|
34
Kornit Digital
KRNT
$709M
| – | – |
-1,420
| Closed | -$216K |
|
|
35
Leidos
LDOS
$14.8B
| – | – |
-258,595
| Closed | -$23M |
|
|
36
iShares MSCI USA Quality Factor ETF
QUAL
$46.3B
| – | – |
-4,012
| Closed | -$584K |
|
|
37
Saic
SAIC
$5.16B
| – | – |
-67,800
| Closed | -$5.67M |
|
Similar funds
AWA
FAM
SHFA
DC
GC
HIG
RCG
FM
Dudley & Shanley's Q1 2022 Portfolio in Review
As of Q1 2022, Dudley & Shanley held 37 positions worth $538M, down 6.9% from $578M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Dudley & Shanley withdrew a net $28.1M in Q1 2022, closing 4 positions and reducing 2 holdings. Its most notable exit was Leidos, an estimated $23M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dudley & Shanley opened a new position in ProShares UltraPro Short S&P 500 worth $1.5M.
- Dudley & Shanley's largest Q1 2022 buy was ProShares UltraPro Short S&P 500: 5,625 shares worth $1.5M.
- Dudley & Shanley added most to Bristol-Myers Squibb in Q1 2022, an estimated $10.8M increase.
- Dudley & Shanley's biggest Q1 2022 reduction was Terminix Global Holdings, Inc., cutting an estimated $11.9M.
- Dudley & Shanley fully exited Leidos in Q1 2022, selling an estimated $23M.
- Dudley & Shanley's ten largest holdings make up 61% of its $538M portfolio in Q1 2022.
- Dudley & Shanley opened 1 new position and closed 4 in Q1 2022.
- Dudley & Shanley's portfolio value fell 6.9% quarter-over-quarter to $538M.
Based on Dudley & Shanley's 13F filing for Q1 2022, filed 18 Apr 2022.